TrialThe oncologist2024

Five-Year Follow-Up of POLARIS-01 Phase II Trial: Toripalimab as Salvage Monotherapy in Chinese Patients With Advanced Melanoma.

Bixia Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.